Cochrane Abstracts
Cholinesterase inhibitors for rarer dementias associated with neurological conditions: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cholinesterase Inhibitors for Rarer Dementias Associated With Neurological Conditions: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438294/all/Long���������������������������acting_muscarinic_antagonist__LAMA__plus_long���������������������������acting_beta���������������������������agonist__LABA__versus_LABA_plus_inhaled_corticosteroid__ICS__for_stable_chronic_obstructive_pulmonary_disease__COPD__Edited__no_change_to_conclusions___comment_added_to_review. Accessed 02 December 2023.
Cholinesterase inhibitors for rarer dementias associated with neurological conditions: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438294/all/Long���������������������������acting_muscarinic_antagonist__LAMA__plus_long���������������������������acting_beta���������������������������agonist__LABA__versus_LABA_plus_inhaled_corticosteroid__ICS__for_stable_chronic_obstructive_pulmonary_disease__COPD__Edited__no_change_to_conclusions___comment_added_to_review. Accessed December 2, 2023.
Cholinesterase inhibitors for rarer dementias associated with neurological conditions: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438294/all/Long���������������������������acting_muscarinic_antagonist__LAMA__plus_long���������������������������acting_beta���������������������������agonist__LABA__versus_LABA_plus_inhaled_corticosteroid__ICS__for_stable_chronic_obstructive_pulmonary_disease__COPD__Edited__no_change_to_conclusions___comment_added_to_review
Cholinesterase Inhibitors for Rarer Dementias Associated With Neurological Conditions: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2023 December 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438294/all/Long���������������������������acting_muscarinic_antagonist__LAMA__plus_long���������������������������acting_beta���������������������������agonist__LABA__versus_LABA_plus_inhaled_corticosteroid__ICS__for_stable_chronic_obstructive_pulmonary_disease__COPD__Edited__no_change_to_conclusions___comment_added_to_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cholinesterase inhibitors for rarer dementias associated with neurological conditions: Cochrane systematic review
ID - 438294
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438294/all/Long���������������������������acting_muscarinic_antagonist__LAMA__plus_long���������������������������acting_beta���������������������������agonist__LABA__versus_LABA_plus_inhaled_corticosteroid__ICS__for_stable_chronic_obstructive_pulmonary_disease__COPD__Edited__no_change_to_conclusions___comment_added_to_review
DB - Evidence Central
DP - Unbound Medicine
ER -
